Ernexa Therapeutics

ERNANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$6.203 M

$3.80 -4.04%

Close of 22 Sept 2026

Revenue

$582.0K

#3524 by revenue

Earnings

-$14.1M

Loss-making

Shares outstanding

1,632,411

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

Ernexa Therapeutics lists more than one class of stock. Company figures above cover all classes combined.

ERNAW

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#455GelteqGELS$6.53M
#456PulmatrixPULM$6.21M
#457Ernexa TherapeuticsERNA$6.20M
#458Bio Green Med SolutionBGMS$6.14M
#459Kairos PharmaKAPA$6.03M

What if Ernexa Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.2T

$18,521,052

Per share 4,873,961× higher

Bitcoin $1.74T

$1,066,922

Per share 280,769× higher

Nvidia $5.52T

$3,378,908

Per share 889,186× higher

Or at a round number

$10.0M $20.0M $50.0M $100.0M

Where these numbers come from

Share counts and financials for Ernexa Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.